| Matthew F Aiken, DO | |
|
4600 Spotsylvania Pkwy, Attn: Hospitalists Office, Fredericksburg, VA 22408-7762 | |
| (540) 498-4950 | |
| (540) 498-4959 |
| Full Name | Matthew F Aiken |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 4600 Spotsylvania Pkwy, Fredericksburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063488450 | NPI | - | NPPES |
| 541951145 | Other | VA | MID ATLANTIC SOLUTIONS |
| 010187982 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0102201615 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Washington Hospital | Fredericksburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Washington Hospital Inc | 0446143820 | 43 |
News Archive
Scientists in the Multisensory Perception and Action Group at the Max Planck Institute for Biological Cybernetics in T-bingen, led by Jan Souman and Marc Ernst, have now presented the first empirical evidence that people really walk in circles when they do not have reliable cues to their walking direction. Their study, published today in the journal Current Biology, examined the walking trajectories of people who walked for several hours in the Sahara desert (Tunisia) and in the Bienwald forest area (Germany).
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Millions of Australians suffering from kidney stones could soon get relief, with researchers discovering a prostrate treatment can also help ease the painful condition.
In cooperation with Amoena Medizin-Orthopädie-Technik GmbH, researchers from the Hohenstein Institute have taken on a highly sensitive yet very important issue. In the framework of the publicly funded research project they developed a special brassiere for breast cancer patients.
Scientists in the United States say an experimental drug may be able to compensate for the genetic error responsible for some cases of Duchenne Muscular Dystrophy (DMD) and cystic fibrosis.
› Verified 4 days ago
| Entity Name | Mary Washington Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013089879 PECOS PAC ID: 0446143820 Enrollment ID: O20040209000155 |
News Archive
Scientists in the Multisensory Perception and Action Group at the Max Planck Institute for Biological Cybernetics in T-bingen, led by Jan Souman and Marc Ernst, have now presented the first empirical evidence that people really walk in circles when they do not have reliable cues to their walking direction. Their study, published today in the journal Current Biology, examined the walking trajectories of people who walked for several hours in the Sahara desert (Tunisia) and in the Bienwald forest area (Germany).
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Millions of Australians suffering from kidney stones could soon get relief, with researchers discovering a prostrate treatment can also help ease the painful condition.
In cooperation with Amoena Medizin-Orthopädie-Technik GmbH, researchers from the Hohenstein Institute have taken on a highly sensitive yet very important issue. In the framework of the publicly funded research project they developed a special brassiere for breast cancer patients.
Scientists in the United States say an experimental drug may be able to compensate for the genetic error responsible for some cases of Duchenne Muscular Dystrophy (DMD) and cystic fibrosis.
› Verified 4 days ago
| Entity Name | Mary Washington Medical Group Hospitalist Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750826277 PECOS PAC ID: 1456629369 Enrollment ID: O20170619001149 |
News Archive
Scientists in the Multisensory Perception and Action Group at the Max Planck Institute for Biological Cybernetics in T-bingen, led by Jan Souman and Marc Ernst, have now presented the first empirical evidence that people really walk in circles when they do not have reliable cues to their walking direction. Their study, published today in the journal Current Biology, examined the walking trajectories of people who walked for several hours in the Sahara desert (Tunisia) and in the Bienwald forest area (Germany).
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Millions of Australians suffering from kidney stones could soon get relief, with researchers discovering a prostrate treatment can also help ease the painful condition.
In cooperation with Amoena Medizin-Orthopädie-Technik GmbH, researchers from the Hohenstein Institute have taken on a highly sensitive yet very important issue. In the framework of the publicly funded research project they developed a special brassiere for breast cancer patients.
Scientists in the United States say an experimental drug may be able to compensate for the genetic error responsible for some cases of Duchenne Muscular Dystrophy (DMD) and cystic fibrosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew F Aiken, DO 4600 Spotsylvania Pkwy, Attn: Hospitalists Office, Fredericksburg, VA 22408-7762 Ph: (540) 498-4950 | Matthew F Aiken, DO 4600 Spotsylvania Pkwy, Attn: Hospitalists Office, Fredericksburg, VA 22408-7762 Ph: (540) 498-4950 |
News Archive
Scientists in the Multisensory Perception and Action Group at the Max Planck Institute for Biological Cybernetics in T-bingen, led by Jan Souman and Marc Ernst, have now presented the first empirical evidence that people really walk in circles when they do not have reliable cues to their walking direction. Their study, published today in the journal Current Biology, examined the walking trajectories of people who walked for several hours in the Sahara desert (Tunisia) and in the Bienwald forest area (Germany).
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
Millions of Australians suffering from kidney stones could soon get relief, with researchers discovering a prostrate treatment can also help ease the painful condition.
In cooperation with Amoena Medizin-Orthopädie-Technik GmbH, researchers from the Hohenstein Institute have taken on a highly sensitive yet very important issue. In the framework of the publicly funded research project they developed a special brassiere for breast cancer patients.
Scientists in the United States say an experimental drug may be able to compensate for the genetic error responsible for some cases of Duchenne Muscular Dystrophy (DMD) and cystic fibrosis.
› Verified 4 days ago
Dr. Thomas P Officer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Park Hill Dr, Fredericksburg, VA 22401 Phone: 540-371-3010 Fax: 540-899-9821 | |
Mrs. Jennifer Lynn Ross, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4510 Plank Rd Ste 200, Fredericksburg, VA 22407 Phone: 540-870-6550 Fax: 540-870-6552 | |
Dr. Robert H Seamon, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 130 Executive Center Pkwy, Fredericksburg, VA 22401 Phone: 540-370-4468 Fax: 540-370-4460 | |
Anson Le Pham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Fall Hill Ave Ste 401, Fredericksburg, VA 22401 Phone: 540-741-3580 | |
Harry Garrett Oldland, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4535 Spotsylvania Pkwy, Fredericksburg, VA 22408 Phone: 540-374-3160 | |
Dien Nguyen, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3031 Plank Rd, Fredericksburg, VA 22401 Phone: 540-736-5043 Fax: 540-736-5044 | |
Shahab S Virani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Thornton St Ste 200, Fredericksburg, VA 22401 Phone: 540-371-6810 Fax: 540-371-9154 |